Literature DB >> 14759235

Actinobacillus actinomycetemcomitans endocarditis.

L Paturel1, J P Casalta, G Habib, M Nezri, D Raoult.   

Abstract

Among the bacteria of the HACEK group, Actinobacillus actinomycetemcomitans is the organism involved most commonly in infective endocarditis. However, the epidemiological and clinical features specifically associated with this species have not been evaluated adequately. Three patients with infective endocarditis caused by A. actinomycetemcomitans seen at the Hospital La Timone (Marseille, France) between 1994 and 2001 are reported. Of 99 cases in the literature, 75% of patients had previous heart disease before infective endocarditis, the portal of entry of which was usually the oral cavity. Among the total of 102 cases, 27 had prosthetic valves. Intermittent fever was observed in all cases, and weight loss and peripheral signs of endocarditis were noteworthy in this study. Anaemia and microscopic haematuria were frequently noted. The disease is insidious, with a mean duration of symptoms of 13 weeks before diagnosis, as confirmed by blood cultures incubated for > 5 days. The aortic valve is most commonly involved, and echocardiographic findings were non-specific. Complications occurred in 63% of patients, with emboli being the most common. The surgery rate was 23.5%. The overall mortality rate was 18%. Of the cases, 76.5% were cured with antibiotics alone, including a simple third-generation cephalosporin or a combination of ampicillin and an aminoglycoside. An antibiotic therapy duration of at least 4 weeks is recommended. Surgical therapy is usually required for haemodynamic reasons. Prophylaxis of A. actinomycetemcomitans endocarditis relies on antibiotic therapy for all cardiac patients at risk before dental procedures. Among 17 patients undergoing dental manipulations, only eight received amoxycillin before the procedure, demonstrating that prophylaxis is far from being systematically prescribed. In conclusion, A. actinomycetemcomitans endocarditis should be highly suspected in patients with previous cardiac disease and for whom symptoms have evolved over a number of weeks or even months.

Entities:  

Mesh:

Year:  2004        PMID: 14759235     DOI: 10.1111/j.1469-0691.2004.00794.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  51 in total

1.  Utility of extended blood culture incubation for isolation of Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella organisms: a retrospective multicenter evaluation.

Authors:  Cathy A Petti; Hasan S Bhally; Melvin P Weinstein; Kim Joho; Teresa Wakefield; L Barth Reller; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Genetic analysis of the requirement for flp-2, tadV, and rcpB in Actinobacillus actinomycetemcomitans biofilm formation.

Authors:  B A Perez; P J Planet; S C Kachlany; M Tomich; D H Fine; D H Figurski
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

Review 3.  NAD+ utilization in Pasteurellaceae: simplification of a complex pathway.

Authors:  Gabriele Gerlach; Joachim Reidl
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

4.  A.actinomycetemcomitans-induced periodontal disease promotes systemic and local responses in rat periodontium.

Authors:  Beatriz de Brito Bezerra; Oelisoa Andriankaja; Jun Kang; Sandra Pacios; Hyung Jin Bae; Yu Li; Vincent Tsiagbe; Helen Schreiner; Daniel H Fine; Dana T Graves
Journal:  J Clin Periodontol       Date:  2012-02-07       Impact factor: 8.728

5.  Gram-negative endocarditis.

Authors:  Milagros P Reyes; Katherine C Reyes
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

6.  HACEK-induced endocarditis.

Authors:  Nancy Wassef; Essam Rizkalla; Naeem Shaukat; Martin Sluka
Journal:  BMJ Case Rep       Date:  2013-05-15

7.  Cardiobacterium hominis endocarditis: A case report and review of the literature.

Authors:  Andrew Walkty
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

8.  EmaA, a potential virulence determinant of Aggregatibacter actinomycetemcomitans in infective endocarditis.

Authors:  Gaoyan Tang; Todd Kitten; Cindy L Munro; George C Wellman; Keith P Mintz
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  Membrane association and destabilization by Aggregatibacter actinomycetemcomitans leukotoxin requires changes in secondary structures.

Authors:  M J Walters; A C Brown; T C Edrington; S Baranwal; Y Du; E T Lally; K Boesze-Battaglia
Journal:  Mol Oral Microbiol       Date:  2013-05-16       Impact factor: 3.563

10.  Membrane morphology and leukotoxin secretion are associated with a novel membrane protein of Aggregatibacter actinomycetemcomitans.

Authors:  Claude V Gallant; Maja Sedic; Erin A Chicoine; Teresa Ruiz; Keith P Mintz
Journal:  J Bacteriol       Date:  2008-07-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.